In an exploratory analysis of REWIND, the hazard of substantive cognitive impairment was reduced by 14% in the dulaglutide group [62]
Tracking weekly changes in hunger, cravings, and blood sugar can help assess progress, especially since results take time and vary by person
The microdosing approach Some clinicians are exploring microdosing of GLP-1 medications specifically for autoimmune patients
Neurobiology of Aging 21, 525-531CrossRefGoogle Scholar 161SantaCruz, K.S., Yazlovitskaya, E., Collins, J
Studies show that people using semaglutide lose about 6 kg after 40 weeks, while those using retatrutide can lose around 20 kg
At the same time, iron-dependent lipoxygenase (LOX) catalyzes polyunsaturated fatty acids (PUFAs) to induce OS, which further alters the permeability of BBB (Figure 2)